CSL Limited is a multinational biotechnology company focused on therapies for serious and rare conditions, with major businesses in plasma-derived products and vaccines. Its operations link donor collection networks with industrial-scale fractionation and biologics manufacturing under stringent quality controls.

Plasma and vaccines

CSL produces immunoglobulins, albumin and other plasma-derived medicines, alongside influenza and other vaccine programs through its divisions. These products are supplied to hospitals and health systems for immunology, critical care and infectious disease prevention.

End-to-end capability

The company’s model integrates collection, processing, manufacturing and global distribution, helping secure reliable supply for complex biologics. R&D and regulatory functions support lifecycle management, safety monitoring and continuous improvement in high-compliance production environments.